Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myopathies, Structural, Congenital | 42 | 2023 | 104 | 9.780 |
Why?
|
Myopathies, Nemaline | 36 | 2021 | 73 | 5.350 |
Why?
|
Protein Tyrosine Phosphatases, Non-Receptor | 22 | 2022 | 69 | 3.850 |
Why?
|
Muscle, Skeletal | 89 | 2024 | 4978 | 2.950 |
Why?
|
Muscle Proteins | 39 | 2024 | 1165 | 2.870 |
Why?
|
Actinin | 23 | 2021 | 165 | 2.310 |
Why?
|
Muscular Diseases | 24 | 2024 | 553 | 2.280 |
Why?
|
Muscular Dystrophies | 33 | 2024 | 393 | 2.170 |
Why?
|
Sarcomeres | 13 | 2021 | 380 | 1.890 |
Why?
|
Anemia, Diamond-Blackfan | 12 | 2018 | 147 | 1.730 |
Why?
|
Zebrafish | 22 | 2024 | 3037 | 1.670 |
Why?
|
Mutation | 78 | 2024 | 30266 | 1.260 |
Why?
|
Tropomyosin | 6 | 2015 | 106 | 1.180 |
Why?
|
Ribosomal Proteins | 10 | 2018 | 370 | 1.170 |
Why?
|
Neonatal Screening | 10 | 2023 | 619 | 1.140 |
Why?
|
Myofibrils | 7 | 2016 | 143 | 1.110 |
Why?
|
Mutation, Missense | 17 | 2024 | 2592 | 1.100 |
Why?
|
Cofilin 2 | 5 | 2020 | 12 | 1.090 |
Why?
|
Genetic Testing | 22 | 2024 | 3591 | 1.050 |
Why?
|
Swimming | 3 | 2023 | 209 | 1.020 |
Why?
|
Muscle Fibers, Skeletal | 16 | 2021 | 553 | 1.010 |
Why?
|
Zebrafish Proteins | 6 | 2020 | 1019 | 0.970 |
Why?
|
Genetic Diseases, X-Linked | 5 | 2023 | 391 | 0.960 |
Why?
|
Selenoproteins | 5 | 2020 | 216 | 0.920 |
Why?
|
Actins | 24 | 2021 | 2065 | 0.910 |
Why?
|
Activin Receptors, Type II | 3 | 2016 | 123 | 0.910 |
Why?
|
Dystrophin | 25 | 2005 | 284 | 0.900 |
Why?
|
Phenotype | 54 | 2024 | 16731 | 0.770 |
Why?
|
Cardiac Myosins | 2 | 2019 | 128 | 0.740 |
Why?
|
Neuromuscular Diseases | 6 | 2019 | 261 | 0.720 |
Why?
|
Genetic Association Studies | 14 | 2024 | 2748 | 0.710 |
Why?
|
Muscle Weakness | 8 | 2023 | 413 | 0.680 |
Why?
|
Microfilament Proteins | 12 | 2020 | 1135 | 0.670 |
Why?
|
Myosin Light Chains | 1 | 2019 | 122 | 0.650 |
Why?
|
Point Mutation | 8 | 2018 | 1596 | 0.640 |
Why?
|
Rare Diseases | 5 | 2024 | 631 | 0.640 |
Why?
|
Muscles | 16 | 2013 | 1582 | 0.620 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2018 | 843 | 0.600 |
Why?
|
Laminin | 3 | 2012 | 406 | 0.600 |
Why?
|
Respiration, Artificial | 3 | 2020 | 2725 | 0.580 |
Why?
|
Exons | 14 | 2023 | 2395 | 0.560 |
Why?
|
RNA, Ribosomal | 4 | 2018 | 227 | 0.550 |
Why?
|
Genetic Predisposition to Disease | 18 | 2023 | 18068 | 0.540 |
Why?
|
Pedigree | 30 | 2024 | 4545 | 0.540 |
Why?
|
Satellite Cells, Skeletal Muscle | 3 | 2014 | 124 | 0.530 |
Why?
|
Disease Models, Animal | 23 | 2022 | 18354 | 0.530 |
Why?
|
Muscular Dystrophy, Duchenne | 7 | 2021 | 271 | 0.510 |
Why?
|
Long QT Syndrome | 6 | 2002 | 472 | 0.490 |
Why?
|
X Chromosome | 9 | 2012 | 819 | 0.480 |
Why?
|
DNA Copy Number Variations | 9 | 2024 | 2055 | 0.450 |
Why?
|
Dog Diseases | 2 | 2015 | 143 | 0.450 |
Why?
|
Infant | 49 | 2024 | 36556 | 0.440 |
Why?
|
Hypertrichosis | 1 | 2013 | 31 | 0.440 |
Why?
|
Child, Preschool | 54 | 2024 | 42683 | 0.440 |
Why?
|
Infant, Newborn | 32 | 2024 | 26428 | 0.430 |
Why?
|
KATP Channels | 1 | 2013 | 49 | 0.430 |
Why?
|
Muscle Fibers, Slow-Twitch | 5 | 2016 | 52 | 0.430 |
Why?
|
Child | 73 | 2024 | 80960 | 0.430 |
Why?
|
Frameshift Mutation | 4 | 2013 | 393 | 0.410 |
Why?
|
Muscle Strength | 4 | 2023 | 641 | 0.410 |
Why?
|
Enzyme Replacement Therapy | 1 | 2013 | 80 | 0.410 |
Why?
|
Humans | 241 | 2024 | 768970 | 0.410 |
Why?
|
Neurofilament Proteins | 1 | 2014 | 337 | 0.400 |
Why?
|
Muscle Contraction | 10 | 2018 | 1209 | 0.400 |
Why?
|
Animals | 82 | 2024 | 169335 | 0.400 |
Why?
|
Osteochondrodysplasias | 1 | 2013 | 183 | 0.400 |
Why?
|
Base Sequence | 26 | 2017 | 12430 | 0.390 |
Why?
|
Protein Interaction Domains and Motifs | 2 | 2013 | 450 | 0.390 |
Why?
|
Myoblasts | 4 | 2018 | 234 | 0.390 |
Why?
|
Protein Isoforms | 11 | 2018 | 1714 | 0.390 |
Why?
|
Parents | 9 | 2022 | 3597 | 0.390 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 5 | 2024 | 185 | 0.380 |
Why?
|
Dystroglycans | 2 | 2011 | 62 | 0.380 |
Why?
|
Genomics | 12 | 2023 | 5928 | 0.380 |
Why?
|
Muscle Hypotonia | 2 | 2024 | 166 | 0.380 |
Why?
|
RNA Splice Sites | 1 | 2012 | 213 | 0.370 |
Why?
|
Genes, Dominant | 7 | 2012 | 856 | 0.360 |
Why?
|
Male | 133 | 2024 | 365203 | 0.360 |
Why?
|
Abnormalities, Multiple | 4 | 2012 | 1423 | 0.360 |
Why?
|
Cardiomegaly | 1 | 2013 | 591 | 0.360 |
Why?
|
Protein Biosynthesis | 4 | 2018 | 2094 | 0.360 |
Why?
|
Ophthalmoplegia | 4 | 1998 | 168 | 0.350 |
Why?
|
Distal Myopathies | 2 | 2024 | 18 | 0.350 |
Why?
|
Health | 2 | 2019 | 398 | 0.340 |
Why?
|
Gene Deletion | 7 | 2018 | 2674 | 0.340 |
Why?
|
Carrier Proteins | 5 | 2018 | 4939 | 0.330 |
Why?
|
Sudden Infant Death | 2 | 2009 | 293 | 0.330 |
Why?
|
Chromosomes, Human, Pair 1 | 6 | 2002 | 640 | 0.330 |
Why?
|
Sequence Analysis, DNA | 11 | 2024 | 4785 | 0.330 |
Why?
|
Genetic Variation | 13 | 2024 | 6611 | 0.320 |
Why?
|
Premature Birth | 2 | 2019 | 1830 | 0.320 |
Why?
|
Ubiquitination | 1 | 2013 | 1010 | 0.320 |
Why?
|
Mice | 41 | 2024 | 82072 | 0.320 |
Why?
|
Drug Discovery | 4 | 2023 | 1068 | 0.310 |
Why?
|
INDEL Mutation | 1 | 2009 | 267 | 0.310 |
Why?
|
Proteins | 2 | 2013 | 6011 | 0.310 |
Why?
|
Genes | 5 | 2003 | 1824 | 0.310 |
Why?
|
Genetic Linkage | 12 | 2015 | 2342 | 0.300 |
Why?
|
Dynamin II | 4 | 2013 | 35 | 0.300 |
Why?
|
Nuclear Proteins | 6 | 2024 | 5804 | 0.300 |
Why?
|
Protein Tyrosine Phosphatases | 2 | 2007 | 458 | 0.300 |
Why?
|
Polymerase Chain Reaction | 16 | 2011 | 6086 | 0.290 |
Why?
|
Mice, Knockout | 16 | 2024 | 14484 | 0.290 |
Why?
|
Gene Expression Profiling | 14 | 2019 | 9549 | 0.290 |
Why?
|
Dependovirus | 5 | 2021 | 721 | 0.280 |
Why?
|
Genotype | 19 | 2024 | 13048 | 0.280 |
Why?
|
Cell Cycle | 5 | 2019 | 2937 | 0.280 |
Why?
|
Thumb | 1 | 2008 | 232 | 0.270 |
Why?
|
Blotting, Western | 11 | 2016 | 5033 | 0.270 |
Why?
|
Developmental Disabilities | 4 | 2020 | 1520 | 0.270 |
Why?
|
Sodium Channels | 3 | 2010 | 341 | 0.260 |
Why?
|
DNA Mutational Analysis | 18 | 2017 | 4124 | 0.260 |
Why?
|
Molecular Sequence Data | 30 | 2014 | 17629 | 0.260 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1941 | 0.260 |
Why?
|
Female | 106 | 2024 | 397515 | 0.260 |
Why?
|
Databases, Genetic | 9 | 2021 | 1758 | 0.260 |
Why?
|
Potassium Channels | 3 | 1998 | 538 | 0.260 |
Why?
|
Heterozygote | 9 | 2023 | 2798 | 0.250 |
Why?
|
Genetic Diseases, Inborn | 3 | 2024 | 606 | 0.250 |
Why?
|
Computational Biology | 5 | 2023 | 3562 | 0.250 |
Why?
|
Chromosomes, Human, Pair 12 | 3 | 1997 | 432 | 0.250 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2460 | 0.250 |
Why?
|
Oligonucleotide Array Sequence Analysis | 12 | 2010 | 3810 | 0.240 |
Why?
|
Genome, Human | 7 | 2024 | 4456 | 0.240 |
Why?
|
Blepharoptosis | 3 | 1998 | 145 | 0.240 |
Why?
|
Psychotic Disorders | 4 | 2023 | 3278 | 0.240 |
Why?
|
Truth Disclosure | 2 | 2019 | 433 | 0.240 |
Why?
|
Amino Acid Sequence | 19 | 2021 | 13427 | 0.230 |
Why?
|
Drosophila Proteins | 1 | 2014 | 1712 | 0.230 |
Why?
|
HSP40 Heat-Shock Proteins | 1 | 2024 | 85 | 0.230 |
Why?
|
Chromosome Mapping | 21 | 2021 | 4625 | 0.230 |
Why?
|
Transcription Factors | 6 | 2021 | 12174 | 0.230 |
Why?
|
Cytoskeletal Proteins | 5 | 2018 | 1328 | 0.230 |
Why?
|
Transcription, Genetic | 7 | 2006 | 7609 | 0.230 |
Why?
|
Genes, Recessive | 8 | 2013 | 625 | 0.220 |
Why?
|
Signal Transduction | 9 | 2021 | 23653 | 0.220 |
Why?
|
Contractile Proteins | 2 | 2003 | 240 | 0.220 |
Why?
|
Fluorescent Antibody Technique, Indirect | 4 | 2012 | 424 | 0.220 |
Why?
|
Chromosome Deletion | 10 | 2016 | 1390 | 0.220 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 168 | 0.220 |
Why?
|
Genetic Counseling | 2 | 2018 | 634 | 0.210 |
Why?
|
Larva | 2 | 2023 | 514 | 0.210 |
Why?
|
Dogs | 8 | 2017 | 3845 | 0.210 |
Why?
|
Longevity | 1 | 2011 | 1077 | 0.210 |
Why?
|
Cleft Palate | 1 | 2008 | 597 | 0.210 |
Why?
|
Adolescent | 40 | 2024 | 89244 | 0.210 |
Why?
|
Genetic Heterogeneity | 3 | 2015 | 737 | 0.210 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2016 | 344 | 0.210 |
Why?
|
Gene Expression Regulation | 13 | 2021 | 11932 | 0.200 |
Why?
|
DNA Primers | 7 | 2012 | 2827 | 0.200 |
Why?
|
Phosphatidylinositol Phosphates | 2 | 2014 | 201 | 0.200 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2019 | 3671 | 0.200 |
Why?
|
RNA, Messenger | 14 | 2020 | 12806 | 0.200 |
Why?
|
Myosin-Light-Chain Kinase | 2 | 2024 | 104 | 0.200 |
Why?
|
Hypophosphatemia | 1 | 2023 | 93 | 0.200 |
Why?
|
Actomyosin | 1 | 2023 | 114 | 0.200 |
Why?
|
GATA1 Transcription Factor | 2 | 2014 | 306 | 0.200 |
Why?
|
Sequence Deletion | 4 | 2012 | 1498 | 0.200 |
Why?
|
Biopsy | 17 | 2019 | 6805 | 0.200 |
Why?
|
DEAD-box RNA Helicases | 2 | 2018 | 385 | 0.200 |
Why?
|
Sarcoplasmic Reticulum | 2 | 2014 | 164 | 0.190 |
Why?
|
Muscle Fibers, Fast-Twitch | 5 | 2016 | 71 | 0.190 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2012 | 2960 | 0.190 |
Why?
|
Adult | 61 | 2024 | 223851 | 0.190 |
Why?
|
JC Virus | 3 | 1994 | 87 | 0.190 |
Why?
|
Directed Molecular Evolution | 1 | 2021 | 165 | 0.170 |
Why?
|
Antigens, Viral, Tumor | 3 | 1990 | 153 | 0.170 |
Why?
|
Potassium Channels, Voltage-Gated | 2 | 1998 | 142 | 0.170 |
Why?
|
Calcium | 7 | 2018 | 5792 | 0.170 |
Why?
|
Glycolysis | 2 | 2009 | 838 | 0.170 |
Why?
|
Gene Expression | 8 | 2018 | 7603 | 0.170 |
Why?
|
Models, Molecular | 8 | 2018 | 5404 | 0.170 |
Why?
|
Amino Acid Transport System y+ | 1 | 2019 | 40 | 0.170 |
Why?
|
Muscle Relaxation | 1 | 2020 | 138 | 0.170 |
Why?
|
Muscle Development | 3 | 2018 | 258 | 0.170 |
Why?
|
Myosin Heavy Chains | 3 | 2023 | 404 | 0.170 |
Why?
|
Microscopy, Electron | 4 | 2017 | 2560 | 0.170 |
Why?
|
Age of Onset | 4 | 2019 | 3346 | 0.160 |
Why?
|
Fatal Outcome | 5 | 2019 | 1836 | 0.160 |
Why?
|
Autistic Disorder | 2 | 2021 | 1240 | 0.160 |
Why?
|
Troponin T | 2 | 2020 | 787 | 0.160 |
Why?
|
Histone Deacetylases | 2 | 2020 | 718 | 0.160 |
Why?
|
Capsid | 1 | 2021 | 435 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
Family | 2 | 2021 | 3208 | 0.160 |
Why?
|
Muscular Dystrophy, Animal | 1 | 2019 | 89 | 0.150 |
Why?
|
Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.150 |
Why?
|
Polyomavirus | 2 | 1990 | 235 | 0.150 |
Why?
|
Sequence Alignment | 5 | 2014 | 2179 | 0.150 |
Why?
|
Blotting, Northern | 6 | 2012 | 1553 | 0.150 |
Why?
|
Eczema | 1 | 2020 | 245 | 0.150 |
Why?
|
Peptide Elongation Factor 1 | 1 | 2017 | 40 | 0.150 |
Why?
|
Haplotypes | 6 | 2010 | 2725 | 0.150 |
Why?
|
DNA-Binding Proteins | 2 | 2009 | 9618 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 2 | 2023 | 3235 | 0.140 |
Why?
|
Myosins | 4 | 2015 | 408 | 0.140 |
Why?
|
Apoptosis Inducing Factor | 1 | 2017 | 51 | 0.140 |
Why?
|
Myasthenic Syndromes, Congenital | 1 | 2017 | 17 | 0.140 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 2017 | 40 | 0.140 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2018 | 2911 | 0.140 |
Why?
|
Hybrid Cells | 4 | 1995 | 421 | 0.140 |
Why?
|
Agrin | 1 | 2017 | 75 | 0.140 |
Why?
|
Oculomotor Nerve | 1 | 1997 | 72 | 0.140 |
Why?
|
Mutagenesis, Insertional | 1 | 2019 | 662 | 0.140 |
Why?
|
Medulla Oblongata | 2 | 2009 | 248 | 0.140 |
Why?
|
Oligonucleotides, Antisense | 1 | 2019 | 461 | 0.140 |
Why?
|
GABA Plasma Membrane Transport Proteins | 1 | 2016 | 30 | 0.140 |
Why?
|
Cell Line | 13 | 2018 | 15604 | 0.140 |
Why?
|
Apoptosis | 4 | 2015 | 9527 | 0.130 |
Why?
|
Disease Progression | 8 | 2021 | 13674 | 0.130 |
Why?
|
Depression, Postpartum | 1 | 2021 | 355 | 0.130 |
Why?
|
Microcephaly | 1 | 2020 | 426 | 0.130 |
Why?
|
Lod Score | 8 | 2001 | 600 | 0.130 |
Why?
|
Health Care Costs | 2 | 2021 | 3270 | 0.130 |
Why?
|
Oculomotor Muscles | 2 | 1998 | 405 | 0.130 |
Why?
|
Gene Transfer Techniques | 1 | 2021 | 1209 | 0.130 |
Why?
|
Cytoskeleton | 3 | 2021 | 1179 | 0.130 |
Why?
|
Ribosomes | 4 | 2018 | 499 | 0.130 |
Why?
|
Charcot-Marie-Tooth Disease | 1 | 2017 | 102 | 0.130 |
Why?
|
Myokymia | 1 | 2015 | 11 | 0.130 |
Why?
|
Diaphragm | 2 | 2014 | 357 | 0.130 |
Why?
|
Kv1.1 Potassium Channel | 1 | 2015 | 31 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 4592 | 0.130 |
Why?
|
Epilepsies, Myoclonic | 1 | 2016 | 85 | 0.130 |
Why?
|
Growth Disorders | 1 | 2020 | 635 | 0.130 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 1998 | 411 | 0.130 |
Why?
|
Craniofacial Abnormalities | 1 | 2018 | 320 | 0.130 |
Why?
|
Muscular Dystrophy, Emery-Dreifuss | 1 | 2015 | 21 | 0.130 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 593 | 0.130 |
Why?
|
Polymorphism, Genetic | 8 | 2012 | 4251 | 0.130 |
Why?
|
Two-Hybrid System Techniques | 2 | 2014 | 463 | 0.120 |
Why?
|
Polymorphism, Single-Stranded Conformational | 5 | 2004 | 326 | 0.120 |
Why?
|
Obesity Hypoventilation Syndrome | 1 | 2015 | 17 | 0.120 |
Why?
|
Cation Transport Proteins | 1 | 1998 | 326 | 0.120 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2017 | 263 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 2018 | 469 | 0.120 |
Why?
|
Cataplexy | 1 | 2015 | 62 | 0.120 |
Why?
|
Dosage Compensation, Genetic | 3 | 1995 | 209 | 0.120 |
Why?
|
Chromosomes, Human, Pair 2 | 5 | 2014 | 313 | 0.120 |
Why?
|
Young Adult | 16 | 2024 | 60131 | 0.120 |
Why?
|
Age Factors | 5 | 2019 | 18435 | 0.120 |
Why?
|
Health Resources | 1 | 2021 | 951 | 0.120 |
Why?
|
Microscopy, Electron, Transmission | 4 | 2012 | 690 | 0.120 |
Why?
|
Mice, Mutant Strains | 2 | 2016 | 1755 | 0.120 |
Why?
|
Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2014 | 14 | 0.120 |
Why?
|
Trans-Activators | 3 | 2021 | 2858 | 0.110 |
Why?
|
Mice, Inbred C57BL | 8 | 2021 | 22379 | 0.110 |
Why?
|
Hepatomegaly | 1 | 2014 | 84 | 0.110 |
Why?
|
Lung | 1 | 2013 | 10099 | 0.110 |
Why?
|
Myotonia Congenita | 1 | 2013 | 16 | 0.110 |
Why?
|
Genetics, Population | 1 | 1999 | 944 | 0.110 |
Why?
|
Embryonic Development | 1 | 2019 | 724 | 0.110 |
Why?
|
Escape Reaction | 1 | 2013 | 57 | 0.110 |
Why?
|
Hypothalamic Diseases | 1 | 2015 | 134 | 0.110 |
Why?
|
Information Storage and Retrieval | 1 | 2019 | 831 | 0.110 |
Why?
|
Turkey | 1 | 2014 | 256 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1038 | 0.110 |
Why?
|
Repressor Proteins | 2 | 2024 | 2986 | 0.110 |
Why?
|
Codon, Terminator | 4 | 2002 | 125 | 0.110 |
Why?
|
Gene Order | 1 | 2013 | 168 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1340 | 0.110 |
Why?
|
Disease | 1 | 2019 | 673 | 0.110 |
Why?
|
Tissue Fixation | 1 | 2014 | 245 | 0.110 |
Why?
|
Ataxia | 1 | 2015 | 307 | 0.110 |
Why?
|
Medical Records | 1 | 2018 | 1411 | 0.110 |
Why?
|
Expressed Sequence Tags | 2 | 2003 | 251 | 0.110 |
Why?
|
Attitude to Health | 2 | 2019 | 2025 | 0.110 |
Why?
|
Polymorphism, Restriction Fragment Length | 3 | 1992 | 767 | 0.110 |
Why?
|
Genetic Vectors | 4 | 2017 | 3412 | 0.100 |
Why?
|
Phosphatidylinositols | 1 | 2014 | 280 | 0.100 |
Why?
|
Walker-Warburg Syndrome | 1 | 2012 | 15 | 0.100 |
Why?
|
Myostatin | 2 | 2011 | 129 | 0.100 |
Why?
|
Cell Membrane | 4 | 2012 | 3659 | 0.100 |
Why?
|
Cohort Studies | 11 | 2024 | 41808 | 0.100 |
Why?
|
Gait | 2 | 2017 | 822 | 0.100 |
Why?
|
Immunohistochemistry | 13 | 2018 | 11116 | 0.100 |
Why?
|
Muscular Atrophy | 1 | 2015 | 335 | 0.100 |
Why?
|
Calmodulin | 2 | 2008 | 241 | 0.100 |
Why?
|
Pyrazines | 2 | 2021 | 1206 | 0.100 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2015 | 268 | 0.100 |
Why?
|
Imidazoles | 2 | 2021 | 1169 | 0.100 |
Why?
|
Nervous System Diseases | 1 | 2023 | 1665 | 0.100 |
Why?
|
Protein Conformation | 4 | 2018 | 3956 | 0.100 |
Why?
|
Glycosyltransferases | 1 | 2012 | 114 | 0.100 |
Why?
|
Selenocysteine | 1 | 2013 | 127 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1682 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 3408 | 0.100 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1992 | 781 | 0.100 |
Why?
|
Gene Expression Regulation, Viral | 2 | 1994 | 435 | 0.100 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 2 | 1988 | 69 | 0.100 |
Why?
|
Gene Duplication | 1 | 2012 | 315 | 0.100 |
Why?
|
Catalysis | 1 | 2013 | 768 | 0.090 |
Why?
|
Amino Acid Substitution | 4 | 2013 | 1742 | 0.090 |
Why?
|
Australia | 3 | 2024 | 1265 | 0.090 |
Why?
|
Protein Stability | 1 | 2013 | 580 | 0.090 |
Why?
|
Sequence Homology, Amino Acid | 5 | 2010 | 2749 | 0.090 |
Why?
|
Schizophrenia | 2 | 2023 | 6987 | 0.090 |
Why?
|
Regeneration | 3 | 2018 | 1524 | 0.090 |
Why?
|
Gravitation | 1 | 2011 | 82 | 0.090 |
Why?
|
Cells, Cultured | 12 | 2021 | 19023 | 0.090 |
Why?
|
In Situ Hybridization | 2 | 2012 | 1904 | 0.090 |
Why?
|
Desmin | 1 | 2010 | 99 | 0.090 |
Why?
|
Gene Frequency | 4 | 2009 | 3626 | 0.090 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 293 | 0.090 |
Why?
|
Forelimb | 1 | 2011 | 116 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 344 | 0.090 |
Why?
|
Comparative Genomic Hybridization | 3 | 2018 | 474 | 0.090 |
Why?
|
Motion | 1 | 2014 | 794 | 0.090 |
Why?
|
Homozygote | 4 | 2017 | 1780 | 0.090 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1752 | 0.090 |
Why?
|
Multigene Family | 4 | 2002 | 1082 | 0.080 |
Why?
|
COS Cells | 2 | 2010 | 1135 | 0.080 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 1 | 2010 | 62 | 0.080 |
Why?
|
Tissue Distribution | 5 | 2019 | 2298 | 0.080 |
Why?
|
Neuromuscular Junction | 1 | 2012 | 407 | 0.080 |
Why?
|
Single-Blind Method | 1 | 2013 | 1586 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2610 | 0.080 |
Why?
|
Quality of Life | 2 | 2022 | 13510 | 0.080 |
Why?
|
Cell Fusion | 2 | 2006 | 294 | 0.080 |
Why?
|
Troponin | 1 | 2013 | 535 | 0.080 |
Why?
|
HeLa Cells | 2 | 2013 | 3076 | 0.080 |
Why?
|
Ribosome Subunits, Large | 1 | 2008 | 4 | 0.080 |
Why?
|
Ribosome Subunits, Small | 1 | 2008 | 5 | 0.080 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2018 | 1508 | 0.080 |
Why?
|
Dinucleoside Phosphates | 1 | 1989 | 70 | 0.080 |
Why?
|
Cell Differentiation | 4 | 2017 | 11684 | 0.080 |
Why?
|
Cloning, Molecular | 8 | 2001 | 4168 | 0.080 |
Why?
|
Cell Transformation, Viral | 2 | 1990 | 530 | 0.080 |
Why?
|
Facies | 2 | 2020 | 224 | 0.080 |
Why?
|
Recombination, Genetic | 3 | 2021 | 1526 | 0.080 |
Why?
|
Mitochondria, Muscle | 2 | 2010 | 172 | 0.080 |
Why?
|
Alleles | 7 | 2023 | 6901 | 0.080 |
Why?
|
Physical Fitness | 2 | 2003 | 744 | 0.080 |
Why?
|
DNA | 13 | 2008 | 7214 | 0.080 |
Why?
|
Respiratory Insufficiency | 3 | 2024 | 1241 | 0.080 |
Why?
|
Genes, Viral | 2 | 1986 | 655 | 0.080 |
Why?
|
Founder Effect | 1 | 2009 | 185 | 0.080 |
Why?
|
RNA, Small Interfering | 3 | 2013 | 3433 | 0.080 |
Why?
|
Blotting, Southern | 6 | 1993 | 777 | 0.080 |
Why?
|
Genetic Markers | 8 | 2004 | 2604 | 0.070 |
Why?
|
Myocardium | 3 | 2014 | 4790 | 0.070 |
Why?
|
Longitudinal Studies | 6 | 2022 | 14794 | 0.070 |
Why?
|
Hand Strength | 1 | 2011 | 466 | 0.070 |
Why?
|
DNA, Complementary | 5 | 2004 | 1990 | 0.070 |
Why?
|
Kinetics | 2 | 2016 | 6332 | 0.070 |
Why?
|
Enzymes | 1 | 2009 | 254 | 0.070 |
Why?
|
Middle Aged | 28 | 2024 | 223737 | 0.070 |
Why?
|
Models, Biological | 3 | 2018 | 9499 | 0.070 |
Why?
|
Myositis, Inclusion Body | 1 | 2009 | 145 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 4 | 2004 | 2474 | 0.070 |
Why?
|
Serotonin | 2 | 2009 | 1043 | 0.070 |
Why?
|
Fatty Liver | 1 | 2014 | 810 | 0.070 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1608 | 0.070 |
Why?
|
Polymyositis | 1 | 2007 | 75 | 0.070 |
Why?
|
Cell Count | 3 | 2012 | 1833 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2542 | 0.070 |
Why?
|
Phosphorylation | 3 | 2024 | 8317 | 0.070 |
Why?
|
Cell Separation | 3 | 2011 | 1728 | 0.070 |
Why?
|
DNA Methylation | 2 | 2019 | 4432 | 0.070 |
Why?
|
Introns | 1 | 2009 | 969 | 0.070 |
Why?
|
Cardiomyopathies | 1 | 2019 | 2057 | 0.070 |
Why?
|
Defective Viruses | 1 | 1986 | 89 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2666 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2754 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2024 | 81903 | 0.070 |
Why?
|
RNA, Ribosomal, 18S | 1 | 2006 | 55 | 0.070 |
Why?
|
Pediatrics | 2 | 2019 | 3628 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 3 | 2011 | 3744 | 0.070 |
Why?
|
Fibroblasts | 5 | 2019 | 4179 | 0.070 |
Why?
|
Mortality | 1 | 2017 | 2914 | 0.070 |
Why?
|
Personal Autonomy | 2 | 2019 | 315 | 0.070 |
Why?
|
Calcium Signaling | 2 | 2018 | 738 | 0.070 |
Why?
|
Simian virus 40 | 1 | 1986 | 292 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 2812 | 0.070 |
Why?
|
Epilepsy | 2 | 2018 | 3326 | 0.070 |
Why?
|
Case-Control Studies | 7 | 2016 | 22296 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2006 | 82 | 0.060 |
Why?
|
Transgenes | 2 | 2021 | 1016 | 0.060 |
Why?
|
MicroRNAs | 2 | 2015 | 3811 | 0.060 |
Why?
|
Receptors, Serotonin | 1 | 2006 | 211 | 0.060 |
Why?
|
Interferon-beta | 1 | 2007 | 349 | 0.060 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 3730 | 0.060 |
Why?
|
Scoliosis | 2 | 2024 | 793 | 0.060 |
Why?
|
Fibrosis | 4 | 1998 | 2080 | 0.060 |
Why?
|
Erythroid Precursor Cells | 1 | 2006 | 212 | 0.060 |
Why?
|
Genetic Research | 2 | 2017 | 173 | 0.060 |
Why?
|
Fatigue | 1 | 2013 | 1557 | 0.060 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1183 | 0.060 |
Why?
|
Arrhythmias, Cardiac | 3 | 2005 | 2258 | 0.060 |
Why?
|
Hematopoiesis | 2 | 2012 | 2059 | 0.060 |
Why?
|
Telephone | 2 | 2020 | 630 | 0.060 |
Why?
|
Down-Regulation | 4 | 2009 | 2942 | 0.060 |
Why?
|
Membrane Proteins | 5 | 2012 | 7885 | 0.060 |
Why?
|
Syndrome | 4 | 2018 | 3274 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2010 | 2067 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3928 | 0.060 |
Why?
|
Immunoblotting | 6 | 2010 | 1647 | 0.060 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2008 | 706 | 0.060 |
Why?
|
Binding Sites | 6 | 2010 | 6023 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1739 | 0.060 |
Why?
|
Species Specificity | 2 | 2021 | 2417 | 0.060 |
Why?
|
Dermatomyositis | 1 | 2007 | 259 | 0.060 |
Why?
|
Motor Activity | 2 | 2012 | 2713 | 0.060 |
Why?
|
Survival Analysis | 3 | 2017 | 10115 | 0.060 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 167 | 0.060 |
Why?
|
Respiratory Function Tests | 2 | 2021 | 1694 | 0.060 |
Why?
|
Phylogeny | 1 | 2012 | 2843 | 0.060 |
Why?
|
Software | 1 | 2018 | 4479 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1300 | 0.060 |
Why?
|
Postmortem Changes | 1 | 2004 | 119 | 0.060 |
Why?
|
Culture Media | 1 | 1986 | 898 | 0.050 |
Why?
|
United States | 5 | 2024 | 73186 | 0.050 |
Why?
|
PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2023 | 17 | 0.050 |
Why?
|
Growth Substances | 1 | 1986 | 760 | 0.050 |
Why?
|
Cluster Analysis | 3 | 2007 | 2732 | 0.050 |
Why?
|
Selenium | 1 | 2006 | 418 | 0.050 |
Why?
|
Calcium Channels, L-Type | 1 | 2005 | 244 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4818 | 0.050 |
Why?
|
Public Health | 1 | 2017 | 2680 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2007 | 910 | 0.050 |
Why?
|
Protein Multimerization | 2 | 2021 | 968 | 0.050 |
Why?
|
Microarray Analysis | 1 | 2006 | 755 | 0.050 |
Why?
|
Bone Marrow Cells | 3 | 2006 | 2414 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2021 | 2885 | 0.050 |
Why?
|
Paraproteinemias | 1 | 2006 | 252 | 0.050 |
Why?
|
Behavior, Animal | 1 | 2011 | 1862 | 0.050 |
Why?
|
Risk Assessment | 3 | 2019 | 24333 | 0.050 |
Why?
|
Diagnosis, Differential | 5 | 2018 | 13021 | 0.050 |
Why?
|
Severity of Illness Index | 3 | 2020 | 15951 | 0.050 |
Why?
|
France | 1 | 2023 | 497 | 0.050 |
Why?
|
Mice, Transgenic | 4 | 2013 | 9565 | 0.050 |
Why?
|
Glycogen | 1 | 2003 | 252 | 0.050 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2001 | 350 | 0.050 |
Why?
|
Syncope | 3 | 2002 | 430 | 0.050 |
Why?
|
Binding, Competitive | 2 | 2001 | 1142 | 0.050 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 1998 | 903 | 0.050 |
Why?
|
RNA | 4 | 2005 | 2727 | 0.050 |
Why?
|
Fetus | 3 | 2006 | 1882 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3139 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2001 | 453 | 0.050 |
Why?
|
Embryo, Nonmammalian | 2 | 2018 | 910 | 0.050 |
Why?
|
Probability | 3 | 2020 | 2483 | 0.050 |
Why?
|
Germany | 1 | 2023 | 883 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7460 | 0.050 |
Why?
|
Appendicitis | 1 | 2008 | 689 | 0.050 |
Why?
|
Sialorrhea | 1 | 2021 | 25 | 0.050 |
Why?
|
Eye Diseases, Hereditary | 1 | 2002 | 124 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2009 | 1904 | 0.050 |
Why?
|
RNA Splicing | 2 | 2018 | 905 | 0.050 |
Why?
|
Serum Response Factor | 1 | 2021 | 78 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2023 | 515 | 0.050 |
Why?
|
Wheelchairs | 1 | 2021 | 78 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2007 | 2360 | 0.040 |
Why?
|
Hemangioma | 1 | 2005 | 727 | 0.040 |
Why?
|
Adenosine Triphosphatases | 2 | 2017 | 842 | 0.040 |
Why?
|
Intermediate Filament Proteins | 1 | 2001 | 262 | 0.040 |
Why?
|
Body Weight | 1 | 2011 | 4628 | 0.040 |
Why?
|
Oligonucleotide Probes | 2 | 1990 | 417 | 0.040 |
Why?
|
Oncogenes | 1 | 1986 | 1236 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2001 | 361 | 0.040 |
Why?
|
Molecular Chaperones | 1 | 2024 | 763 | 0.040 |
Why?
|
Eye Abnormalities | 1 | 2002 | 243 | 0.040 |
Why?
|
Cell Division | 2 | 2003 | 4478 | 0.040 |
Why?
|
Antigens, CD34 | 2 | 2017 | 656 | 0.040 |
Why?
|
Models, Animal | 2 | 2017 | 2122 | 0.040 |
Why?
|
Valproic Acid | 1 | 2022 | 444 | 0.040 |
Why?
|
Myositis | 1 | 2002 | 269 | 0.040 |
Why?
|
Intubation, Gastrointestinal | 1 | 2020 | 166 | 0.040 |
Why?
|
North America | 1 | 2003 | 1290 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 913 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2130 | 0.040 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1999 | 167 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 422 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4290 | 0.040 |
Why?
|
DNA, Satellite | 2 | 1996 | 67 | 0.040 |
Why?
|
Rhabdomyolysis | 1 | 2020 | 150 | 0.040 |
Why?
|
Aging | 3 | 2005 | 8745 | 0.040 |
Why?
|
Siblings | 2 | 2019 | 828 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2001 | 327 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1999 | 277 | 0.040 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 1998 | 72 | 0.040 |
Why?
|
Histone Code | 1 | 2019 | 160 | 0.040 |
Why?
|
Transfection | 5 | 2010 | 5763 | 0.040 |
Why?
|
Ethics Committees, Research | 1 | 2019 | 196 | 0.040 |
Why?
|
Muscular Atrophy, Spinal | 2 | 2002 | 261 | 0.040 |
Why?
|
PAX2 Transcription Factor | 1 | 2018 | 86 | 0.040 |
Why?
|
Gastrostomy | 1 | 2020 | 325 | 0.040 |
Why?
|
Endothelial Cells | 2 | 2008 | 3592 | 0.040 |
Why?
|
Leg | 1 | 2003 | 1089 | 0.040 |
Why?
|
Exotropia | 1 | 1998 | 64 | 0.040 |
Why?
|
Vital Capacity | 1 | 2020 | 996 | 0.040 |
Why?
|
Codon, Nonsense | 1 | 1999 | 287 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 212 | 0.040 |
Why?
|
Harm Reduction | 1 | 2019 | 143 | 0.040 |
Why?
|
Cell Nucleolus | 1 | 2018 | 156 | 0.040 |
Why?
|
Creatine Kinase | 2 | 1996 | 684 | 0.040 |
Why?
|
Allyl Compounds | 1 | 2017 | 22 | 0.040 |
Why?
|
Collagen Type VI | 1 | 2017 | 26 | 0.040 |
Why?
|
Chromatin | 1 | 1989 | 2981 | 0.040 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1998 | 310 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3836 | 0.040 |
Why?
|
Sports | 1 | 2003 | 703 | 0.030 |
Why?
|
Tetany | 1 | 2016 | 13 | 0.030 |
Why?
|
Neoplasms | 1 | 2006 | 22389 | 0.030 |
Why?
|
Strabismus | 2 | 2002 | 320 | 0.030 |
Why?
|
Morphogenesis | 1 | 2021 | 747 | 0.030 |
Why?
|
Integrins | 1 | 2021 | 843 | 0.030 |
Why?
|
Failure to Thrive | 1 | 2017 | 140 | 0.030 |
Why?
|
Parent-Child Relations | 1 | 2021 | 773 | 0.030 |
Why?
|
Tracheostomy | 1 | 2021 | 430 | 0.030 |
Why?
|
Parenting | 1 | 2022 | 709 | 0.030 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2000 | 336 | 0.030 |
Why?
|
Mobility Limitation | 1 | 2020 | 409 | 0.030 |
Why?
|
DNA Probes | 4 | 1990 | 543 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 1999 | 1216 | 0.030 |
Why?
|
Isomerism | 1 | 1996 | 198 | 0.030 |
Why?
|
Insurance Claim Review | 1 | 2021 | 746 | 0.030 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 80 | 0.030 |
Why?
|
Placenta | 1 | 2005 | 1725 | 0.030 |
Why?
|
Electron Transport | 1 | 2017 | 211 | 0.030 |
Why?
|
Glycoproteins | 2 | 2005 | 2202 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2018 | 16053 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 557 | 0.030 |
Why?
|
Globins | 1 | 2017 | 405 | 0.030 |
Why?
|
Alternative Splicing | 2 | 2014 | 1105 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2019 | 7148 | 0.030 |
Why?
|
Glucuronidase | 1 | 2017 | 205 | 0.030 |
Why?
|
Mitochondria | 2 | 2021 | 3682 | 0.030 |
Why?
|
Neural Conduction | 1 | 2017 | 443 | 0.030 |
Why?
|
Anticipation, Psychological | 1 | 2016 | 91 | 0.030 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3626 | 0.030 |
Why?
|
Erythroid Cells | 1 | 2017 | 238 | 0.030 |
Why?
|
Reflex | 1 | 2017 | 375 | 0.030 |
Why?
|
Molecular Biology | 1 | 1998 | 573 | 0.030 |
Why?
|
Prospective Studies | 5 | 2022 | 54962 | 0.030 |
Why?
|
Brain | 8 | 2005 | 27453 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2023 | 1966 | 0.030 |
Why?
|
Gait Disorders, Neurologic | 1 | 2017 | 243 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2007 | 20245 | 0.030 |
Why?
|
Aged | 13 | 2019 | 171786 | 0.030 |
Why?
|
Amblyopia | 1 | 1997 | 152 | 0.030 |
Why?
|
Cyclin E | 1 | 2015 | 156 | 0.030 |
Why?
|
Proteomics | 2 | 2024 | 3914 | 0.030 |
Why?
|
Action Potentials | 2 | 2017 | 1838 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2021 | 802 | 0.030 |
Why?
|
Research Personnel | 1 | 2019 | 590 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2019 | 683 | 0.030 |
Why?
|
Confidentiality | 1 | 2019 | 606 | 0.030 |
Why?
|
Reference Values | 4 | 2006 | 4940 | 0.030 |
Why?
|
Pilot Projects | 2 | 2021 | 8748 | 0.030 |
Why?
|
Patient Selection | 2 | 2018 | 4265 | 0.030 |
Why?
|
Escherichia coli | 1 | 2006 | 4213 | 0.030 |
Why?
|
Ion Channel Gating | 2 | 2009 | 429 | 0.030 |
Why?
|
CpG Islands | 1 | 2019 | 1210 | 0.030 |
Why?
|
Phosphoglycerate Kinase | 2 | 1995 | 66 | 0.030 |
Why?
|
Transduction, Genetic | 1 | 2017 | 902 | 0.030 |
Why?
|
New Hampshire | 1 | 1994 | 174 | 0.030 |
Why?
|
Apolipoprotein A-II | 1 | 1994 | 41 | 0.030 |
Why?
|
Neurons | 3 | 2009 | 9519 | 0.030 |
Why?
|
Birefringence | 1 | 2013 | 54 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 1999 | 2000 | 0.030 |
Why?
|
Respiration Disorders | 1 | 2017 | 365 | 0.030 |
Why?
|
Genes, Retinoblastoma | 1 | 1994 | 125 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2017 | 916 | 0.030 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2014 | 82 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2019 | 789 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 229 | 0.030 |
Why?
|
Freezing | 1 | 2014 | 311 | 0.030 |
Why?
|
Electrocardiography | 4 | 2002 | 6413 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2021 | 1839 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2018 | 10486 | 0.030 |
Why?
|
Electroencephalography | 2 | 2019 | 6317 | 0.030 |
Why?
|
Glioma | 1 | 1988 | 3532 | 0.030 |
Why?
|
Ontario | 1 | 1994 | 403 | 0.030 |
Why?
|
Mitochondrial Diseases | 1 | 2017 | 344 | 0.030 |
Why?
|
Cyclin D1 | 1 | 2015 | 453 | 0.030 |
Why?
|
Gene Amplification | 1 | 1998 | 1099 | 0.030 |
Why?
|
NAD | 1 | 2017 | 618 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2018 | 1564 | 0.030 |
Why?
|
Erythropoiesis | 1 | 2017 | 693 | 0.030 |
Why?
|
Access to Information | 1 | 2016 | 317 | 0.030 |
Why?
|
Open Reading Frames | 2 | 2012 | 818 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2018 | 1040 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 2025 | 0.030 |
Why?
|
PAX7 Transcription Factor | 1 | 2012 | 55 | 0.030 |
Why?
|
Pyridostigmine Bromide | 1 | 2012 | 32 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2017 | 610 | 0.030 |
Why?
|
Organ Specificity | 2 | 2004 | 1970 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 203 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6232 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2021 | 1894 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2014 | 457 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2023 | 65480 | 0.020 |
Why?
|
Family Health | 2 | 2012 | 1255 | 0.020 |
Why?
|
Body Size | 1 | 2015 | 463 | 0.020 |
Why?
|
Informed Consent | 1 | 2018 | 1010 | 0.020 |
Why?
|
Spectrin | 1 | 1992 | 176 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2003 | 2905 | 0.020 |
Why?
|
Antibodies | 2 | 1997 | 2422 | 0.020 |
Why?
|
Motor Neurons | 1 | 2017 | 872 | 0.020 |
Why?
|
Electromyography | 1 | 2017 | 1401 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10400 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 872 | 0.020 |
Why?
|
Neuregulin-1 | 1 | 2012 | 136 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1658 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2019 | 3612 | 0.020 |
Why?
|
Retina | 1 | 2002 | 2661 | 0.020 |
Why?
|
Receptors, Cholinergic | 1 | 2012 | 244 | 0.020 |
Why?
|
Skin | 2 | 2019 | 4506 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2005 | 8664 | 0.020 |
Why?
|
Plasmids | 2 | 1986 | 2269 | 0.020 |
Why?
|
Information Dissemination | 1 | 2019 | 1141 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1057 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2015 | 718 | 0.020 |
Why?
|
Peripheral Nerves | 1 | 2015 | 492 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1560 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1997 | 2525 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2041 | 0.020 |
Why?
|
Mothers | 1 | 2021 | 2209 | 0.020 |
Why?
|
Methylprednisolone | 1 | 1992 | 386 | 0.020 |
Why?
|
Leukocytes | 1 | 2018 | 2034 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2014 | 726 | 0.020 |
Why?
|
Rotarod Performance Test | 1 | 2010 | 63 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1373 | 0.020 |
Why?
|
Molecular Weight | 1 | 1992 | 2173 | 0.020 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2012 | 414 | 0.020 |
Why?
|
Intermediate Filaments | 1 | 2010 | 171 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9684 | 0.020 |
Why?
|
Rabbits | 1 | 1996 | 4774 | 0.020 |
Why?
|
Blood Proteins | 1 | 1995 | 1191 | 0.020 |
Why?
|
Mitosis | 1 | 2015 | 1181 | 0.020 |
Why?
|
Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.020 |
Why?
|
Ornithine Carbamoyltransferase | 1 | 1989 | 25 | 0.020 |
Why?
|
Cricetinae | 2 | 1995 | 2423 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 1999 | 2820 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 862 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2014 | 59739 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1203 | 0.020 |
Why?
|
Fluorescence | 1 | 1992 | 757 | 0.020 |
Why?
|
Cadherins | 1 | 2014 | 906 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2021 | 1946 | 0.020 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3713 | 0.020 |
Why?
|
Regression Analysis | 2 | 2016 | 6346 | 0.020 |
Why?
|
Factor IX | 1 | 1989 | 76 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26395 | 0.020 |
Why?
|
Nerve Tissue Proteins | 2 | 1999 | 4413 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 1058 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 1995 | 1091 | 0.020 |
Why?
|
Extremities | 1 | 2014 | 870 | 0.020 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 1988 | 16 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3953 | 0.020 |
Why?
|
Autophagy | 1 | 2017 | 1351 | 0.020 |
Why?
|
Insurance, Health | 1 | 2021 | 2518 | 0.020 |
Why?
|
Calpain | 1 | 2009 | 146 | 0.020 |
Why?
|
Protein Binding | 2 | 2014 | 9344 | 0.020 |
Why?
|
Caregivers | 1 | 2021 | 2308 | 0.020 |
Why?
|
Emotions | 2 | 2016 | 2768 | 0.020 |
Why?
|
Nuclear Envelope | 1 | 2009 | 163 | 0.020 |
Why?
|
Cytosine | 1 | 1989 | 213 | 0.020 |
Why?
|
Guanine | 1 | 1989 | 280 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2011 | 1683 | 0.020 |
Why?
|
Child Development | 1 | 2019 | 2336 | 0.020 |
Why?
|
Sarcolemma | 2 | 1999 | 66 | 0.020 |
Why?
|
Homeostasis | 2 | 2009 | 3347 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 1731 | 0.020 |
Why?
|
Health Status | 1 | 2021 | 4095 | 0.020 |
Why?
|
Cost of Illness | 1 | 2017 | 1960 | 0.020 |
Why?
|
Neural Crest | 1 | 1990 | 278 | 0.020 |
Why?
|
Risk Factors | 4 | 2021 | 74976 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 930 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2008 | 323 | 0.020 |
Why?
|
Jews | 1 | 2009 | 359 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2012 | 1074 | 0.020 |
Why?
|
Automation | 1 | 2009 | 589 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1989 | 584 | 0.020 |
Why?
|
Viral Proteins | 1 | 1994 | 1802 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1667 | 0.020 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 556 | 0.020 |
Why?
|
Azacitidine | 1 | 1988 | 336 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2009 | 344 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2016 | 1876 | 0.020 |
Why?
|
Mutagenesis | 1 | 2010 | 1229 | 0.020 |
Why?
|
Receptor, Serotonin, 5-HT1A | 1 | 2006 | 58 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2017 | 2682 | 0.020 |
Why?
|
Gene Targeting | 1 | 2010 | 841 | 0.020 |
Why?
|
Meningioma | 1 | 1995 | 1226 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2990 | 0.020 |
Why?
|
Seizures | 1 | 2019 | 3000 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2014 | 2916 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3629 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1995 | 2452 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1769 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6547 | 0.020 |
Why?
|
Meningeal Neoplasms | 1 | 1995 | 1258 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2011 | 840 | 0.020 |
Why?
|
Cell Fractionation | 1 | 2006 | 247 | 0.020 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 58 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2017 | 12801 | 0.020 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1986 | 257 | 0.020 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1177 | 0.020 |
Why?
|
Cholesterol | 1 | 2015 | 2913 | 0.020 |
Why?
|
Receptors, Mitogen | 1 | 2005 | 61 | 0.020 |
Why?
|
Oligodendroglia | 1 | 1990 | 540 | 0.020 |
Why?
|
Mice, Inbred mdx | 1 | 2005 | 90 | 0.020 |
Why?
|
Calcium Channels | 1 | 2009 | 624 | 0.020 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2008 | 394 | 0.020 |
Why?
|
Electrophoresis | 1 | 2005 | 226 | 0.020 |
Why?
|
Spectrophotometry | 1 | 2005 | 292 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1992 | 1780 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2009 | 997 | 0.020 |
Why?
|
Pituitary Neoplasms | 1 | 1994 | 1326 | 0.020 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 1986 | 209 | 0.020 |
Why?
|
Models, Genetic | 2 | 2012 | 3449 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2008 | 705 | 0.020 |
Why?
|
Fetal Diseases | 1 | 1990 | 916 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3112 | 0.020 |
Why?
|
Epithelium | 1 | 1990 | 1607 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2017 | 1891 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 1986 | 342 | 0.020 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2006 | 326 | 0.010 |
Why?
|
Qualitative Research | 1 | 2016 | 3143 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1902 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1992 | 3813 | 0.010 |
Why?
|
Karyotyping | 1 | 1986 | 1177 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2009 | 1680 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2007 | 948 | 0.010 |
Why?
|
Centrosome | 1 | 2005 | 210 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3463 | 0.010 |
Why?
|
RNA, Complementary | 1 | 2003 | 46 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8094 | 0.010 |
Why?
|
RNA Probes | 1 | 2003 | 111 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4926 | 0.010 |
Why?
|
Statistical Distributions | 1 | 2003 | 63 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 1990 | 1275 | 0.010 |
Why?
|
Adenoma | 1 | 1994 | 2163 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 2007 | 947 | 0.010 |
Why?
|
Epitopes | 1 | 1989 | 2529 | 0.010 |
Why?
|
Xenopus | 1 | 2005 | 711 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9377 | 0.010 |
Why?
|
DNA, Viral | 1 | 1990 | 2205 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3450 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 2003 | 316 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10592 | 0.010 |
Why?
|
Ocular Hypotension | 1 | 2002 | 23 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5793 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3608 | 0.010 |
Why?
|
Electrophysiology | 1 | 2005 | 1266 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3819 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2014 | 4528 | 0.010 |
Why?
|
Astrocytes | 1 | 1990 | 1349 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2009 | 2204 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36854 | 0.010 |
Why?
|
Gene Components | 1 | 2001 | 27 | 0.010 |
Why?
|
Muridae | 1 | 2001 | 55 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4919 | 0.010 |
Why?
|
Cognition Disorders | 1 | 1996 | 3985 | 0.010 |
Why?
|
Prognosis | 2 | 2001 | 30046 | 0.010 |
Why?
|
Glycine | 1 | 2005 | 672 | 0.010 |
Why?
|
Histocytochemistry | 1 | 2002 | 699 | 0.010 |
Why?
|
Depression | 1 | 2021 | 8231 | 0.010 |
Why?
|
Molecular Probes | 1 | 2003 | 309 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6236 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2008 | 1855 | 0.010 |
Why?
|
Endocytosis | 1 | 2005 | 959 | 0.010 |
Why?
|
Cadaver | 1 | 2005 | 1366 | 0.010 |
Why?
|
Ultrasonography | 1 | 2014 | 6002 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2005 | 1866 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1988 | 6131 | 0.010 |
Why?
|
Physical Endurance | 1 | 2003 | 370 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 822 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2011 | 5906 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15471 | 0.010 |
Why?
|
Oocytes | 1 | 2005 | 1172 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2002 | 927 | 0.010 |
Why?
|
Restriction Mapping | 2 | 1991 | 849 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 1991 | 5801 | 0.010 |
Why?
|
Sex Factors | 2 | 2005 | 10633 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21547 | 0.010 |
Why?
|
Neuropilin-1 | 1 | 1999 | 90 | 0.010 |
Why?
|
Optic Nerve | 1 | 2002 | 571 | 0.010 |
Why?
|
Running | 1 | 2003 | 490 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5716 | 0.010 |
Why?
|
Up-Regulation | 1 | 2007 | 4148 | 0.010 |
Why?
|
Utrophin | 1 | 1997 | 15 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2005 | 1629 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14201 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2003 | 3057 | 0.010 |
Why?
|
Nuclear Family | 1 | 1999 | 311 | 0.010 |
Why?
|
RNA Interference | 1 | 2006 | 2835 | 0.010 |
Why?
|
Precipitin Tests | 1 | 1998 | 816 | 0.010 |
Why?
|
Acute Disease | 1 | 2008 | 7245 | 0.010 |
Why?
|
Kv1.4 Potassium Channel | 1 | 1997 | 3 | 0.010 |
Why?
|
Neuronal Apoptosis-Inhibitory Protein | 1 | 1996 | 11 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3621 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4712 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1996 | 113 | 0.010 |
Why?
|
Dimerization | 1 | 1998 | 886 | 0.010 |
Why?
|
Gene Library | 1 | 1999 | 1062 | 0.010 |
Why?
|
Ion Channels | 1 | 2001 | 1043 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 1995 | 65 | 0.010 |
Why?
|
Crohn Disease | 1 | 2008 | 2294 | 0.010 |
Why?
|
Bone Marrow | 1 | 2006 | 2936 | 0.010 |
Why?
|
Neutrophils | 1 | 2008 | 3785 | 0.010 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1996 | 387 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40261 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2001 | 1676 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2001 | 1243 | 0.010 |
Why?
|
Macrophages | 1 | 1990 | 5801 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1996 | 9213 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1995 | 348 | 0.010 |
Why?
|
Proteolipids | 1 | 1994 | 112 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1991 | 9264 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 1996 | 785 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 4428 | 0.010 |
Why?
|
Genome | 1 | 2001 | 1754 | 0.010 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1995 | 481 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2001 | 1894 | 0.010 |
Why?
|
Methylation | 1 | 1995 | 1078 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2001 | 1568 | 0.010 |
Why?
|
Linear Models | 1 | 2002 | 5891 | 0.010 |
Why?
|
Glaucoma | 1 | 2002 | 1194 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1998 | 1191 | 0.010 |
Why?
|
Brain Chemistry | 1 | 1995 | 959 | 0.010 |
Why?
|
Antisense Elements (Genetics) | 1 | 1991 | 37 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2019 | 21188 | 0.010 |
Why?
|
Rats | 2 | 1998 | 23786 | 0.010 |
Why?
|
Genomic Library | 1 | 1991 | 189 | 0.010 |
Why?
|
Lymphocytes | 1 | 1998 | 2614 | 0.010 |
Why?
|
DNA Restriction Enzymes | 1 | 1990 | 548 | 0.010 |
Why?
|
Deoxyribonuclease HindIII | 1 | 1989 | 14 | 0.010 |
Why?
|
Reading Frames | 1 | 1989 | 16 | 0.010 |
Why?
|
Sarcoma | 1 | 2001 | 1806 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1999 | 6512 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1992 | 499 | 0.000 |
Why?
|
Antibody Specificity | 1 | 1991 | 1065 | 0.000 |
Why?
|
DNA, Neoplasm | 1 | 1994 | 1748 | 0.000 |
Why?
|
Synapses | 1 | 1998 | 1764 | 0.000 |
Why?
|
Cross Reactions | 1 | 1989 | 828 | 0.000 |
Why?
|
Kidney Failure, Chronic | 1 | 2000 | 2493 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1998 | 8144 | 0.000 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1997 | 2893 | 0.000 |
Why?
|
Survival Rate | 1 | 2001 | 12873 | 0.000 |
Why?
|
Sleep | 1 | 2001 | 4820 | 0.000 |
Why?
|
Pregnancy | 1 | 2006 | 30265 | 0.000 |
Why?
|
Hippocampus | 1 | 1997 | 3782 | 0.000 |
Why?
|
Exercise | 1 | 2001 | 5954 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2005 | 13594 | 0.000 |
Why?
|
Kidney | 1 | 1995 | 7058 | 0.000 |
Why?
|